Clinical Trial Update: Safety and Efficacy Study of MT-2990 in Women With Endometriosis [Phase 2]

View source ↗

Summary

Phase 2 results from a safety and efficacy study of MT-2990 in women with endometriosis have been completed and posted. The trial evaluated MT-2990 for endometr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• MT-2990

Snippet

Sponsor: Tanabe Pharma America, Inc. | Conditions: Endometrial Related Pain | Phase 2 | Status: COMPLETED | Results posted: 2024-07-10